FDA approves high-dose Fluzone for older patients

12/23/2009 | Reuters

Sanofi Pasteur secured FDA approval to promote a high-dose formulation of its Fluzone seasonal flu vaccine for people 65 and older. Sanofi's application was supported by clinical data showing the superiority of high-dose Fluzone over its original formulation in eliciting an immune response.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA